2-(tert-Butyl)nicotinaldehyde

Catalog No. :
ACTFEX943
CAS No. :
1184658-38-5
Molecular Formula :
C10H13NO
Molecular Weight :
163.22

IUPAC Name:2-(tert-butyl)nicotinaldehyde

2-(tert-Butyl)nicotinaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$355.00Login to see priceIn stockInquiry
250mg95%$569.00Login to see priceIn stockInquiry
500mg95%$947.00Login to see priceInquiryInquiry
1g95%$1419.00Login to see priceInquiryInquiry
5g95%$4255.00Login to see priceInquiryInquiry
10g95%$7092.00Login to see priceInquiryInquiry
25g95%$14183.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(tert-Butyl)nicotinaldehyde
IUPAC Name2-(tert-butyl)nicotinaldehyde
MDL No.MFCD18256098
Molecular FormulaC10H13NO
Molecular Weight163.22
SMILESO=CC1=C(C(C)(C)C)N=CC=C1
InChI KeyTYTIYUJGJVZJHO-UHFFFAOYSA-N
Synonym2-tert-Butyl-pyridine-3-carbaldehyde;2-(tert-butyl)nicotinaldehyde;3-Pyridinecarboxaldehyde, 2-(1,1-dimethylethyl)-
CAS No.1184658-38-5
PubChem CID20585692

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTFEX943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPSTE786 route compound structure diagram
    ACPSTE7862383997-68-8 In Stock
  2. Then
  3. ACTFEX943 route product structure diagram
    ACTFEX9431184658-38-5 In Stock
Inquiry

2. ACTFEX943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACREFZ950 route compound structure diagram
    ACREFZ9505944-41-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTFEX943 route product structure diagram
    ACTFEX9431184658-38-5 In Stock
Inquiry

Comments (0)